Phase II study of high-dose chemotherapy before radiation in children with newly diagnosed high-grade astrocytoma: Final analysis of Children's Cancer Group Study 9933

Cancer

Volumn 104, Issue 12, 2005, Pages 2862-2871

  MacDonald, Tobey J ^a   Arenson, Edward B ^b   Ater, Joann ^c   Sposto, Richard ^d   Bevan, Herbert E ^e   Bruner, Janet ^c   Deutsch, Melvin ^f   Kurczynski, Elizabeth ^g   Luerssen, Thomas ^h   McGuire Cullen, Patricia ^b   O'Brien, Richard ⁱ   Shah, Narayan ^j   Steinbok, Paul ^k   Strain, John ^l   Thomson, John ⁱ   Holmes, Emi ^m   Vezina, Gilbert ^a   Yates, Allan ⁿ   Phillips, Peter ^o   Packer, Roger ^a  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b PRESBYTERIAN ST LUKE S MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d CHILDREN S HOSPITAL LOS ANGELES   (United States)

^e CHILDREN S HOSPITAL OF THE KING S DAUGHTERS   (United States)

^f CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^g WEST VIRGINIA UNIVERSITY   (United States)

^h INDIANA UNIVERSITY   (United States)

ⁱ PRIMARY CHILDREN'S MEDICAL CENTER   (United States)

^j GEISINGER MEDICAL CENTER   (United States)

^k BC CHILDREN S HOSPITAL   (Canada)

^l CHILDREN S HOSPITAL   (United States)

^m CHILDREN S ONCOLOGY GROUP   (United States)

ⁿ NATIONWIDE CHILDREN S HOSPITAL   (United States)

^o CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

more..

Author keywords

Children; phase II study; High dose chemotherapy; High grade astrocytoma

Indexed keywords

CARBOPLATIN; CARMUSTINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; LOMUSTINE; MESNA; PREDNISONE; THIOTEPA; VINCRISTINE; SODIUM;

ADOLESCENT; ADULT; ALLERGY; ASTROCYTOMA; ATAXIA; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM DISEASE; CHILDHOOD CANCER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; ELECTROLYTE DISTURBANCE; FEMALE; GLIOBLASTOMA; HEMATURIA; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; MUSCLE WEAKNESS; NAUSEA AND VOMITING; NEURORADIOLOGY; PERIPHERAL NEUROPATHY; PHASE 2 CLINICAL TRIAL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REVIEW; SCHOOL CHILD; SEIZURE; ABNORMAL BLOOD PRESSURE; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CHEMORADIOTHERAPY; CHILD; DOSE RESPONSE; EVENT FREE SURVIVAL; HISTOLOGY; INDUCTION CHEMOTHERAPY; KIDNEY DISEASE; MAINTENANCE CHEMOTHERAPY; MULTIPLE CYCLE TREATMENT; NAUSEA; OVERALL SURVIVAL; SURVIVAL RATE; UNSPECIFIED SIDE EFFECT; UROGENITAL TRACT DISEASE; VOMITING;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN STEM NEOPLASMS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLIOBLASTOMA; HUMANS; MALE; NEOADJUVANT THERAPY; NEOPLASM STAGING; PROBABILITY; PROGNOSIS; PROSPECTIVE STUDIES; RADIOTHERAPY, HIGH-ENERGY; REFERENCE VALUES; RISK ASSESSMENT; SPINAL CORD NEOPLASMS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 29144459136     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21593     Document Type: Review

References (35)

1. Rilliet B, Vernet O. Gliomas in children: a review. Childs Nerv Syst. 2000;16:735-741.
2. Wisoff JH, Boyett JM, Berger MS, et al. Current neurosurgical management and the impact of the extent of resection in the treatment of malignant gliomas of childhood: a report of the Children's Cancer Group trial no. CCG-945. J Neurosurg. 1998;89:52-59.
3. van den Hauwe L, Parizel PM, Martin JJ, et al. Postmortem MRI of the brain with neuropathological correlation. Neuroradiology. 1995;37:343-349.
4. Leibel SA, Sheline GE, Wara WM, et al. The role of radiation therapy in the treatment of astrocytomas. Cancer. 1975;35:1551-1557.
5. Sheline GE. Radiotherapy for high grade gliomas. Int J Radiat Oncol Biol Phys. 1990;18:793-803.
6. Dohrmann GJ, Farwell JR, Flannery JT. Glioblastoma multiforme in children. J Neurosurg. 1976;44:442-448.
7. Marchese MJ, Chang CH. Malignant astrocytic gliomas in children. Cancer. 1990;65:2771-2778.
8. Sposto R, Ertel IJ, Jenkin RD, et al. The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Childrens Cancer Study Group. J Neurooncol. 1989;7:165-177.
9. Finlay JL, Boyett JM, Yates AJ, et al. Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Children's Cancer Group. J Clin Oncol. 1995;13:112-123.
10. Allen JC, Helson L. High-dose cyclophosphamide chemotherapy for recurrent CNS tumors in children. J Neurosurg. 1981;55:749-756.
11. Abrahamsen TG, Lange BJ, Packer RJ, et al. A phase I and II trial of dose-intensified cyclophosphamide and GM-CSF in pediatric malignant brain tumors. J Pediatr Hematol Oncol. 1995;17:134-139.
12. Yule SM, Foreman NK, Mitchell C, et al. High-dose cyclophosphamide for poor-prognosis and recurrent pediatric brain tumors: a dose-escalation study. J Clin Oncol. 1997;15:3258-3265.
13. McCowage GB, Friedman HS, Moghrabi A, et al. Activity of high-dose cyclophosphamide in the treatment of childhood malignant gliomas. Med Pediatr Oncol. 1998;30:75-80.
14. Heideman RL, Douglass EC, Langston IA, et al. A phase II study of every other day high-dose ifosfamide in pediatric brain tumors: a Pediatric Oncology Group Study. J Neurooncol. 1995;25:77-84.
15. Kuhl J, Muller HL, Berthold F, et al. Preradiation chemotherapy of children and young adults with malignant brain tumors: results of the German pilot trial HIT'88/'89. Klin Padiatr. 1998;210:227-233.
16. Castello MA, Clerico A, Deb G, et al. High-dose carboplatin in combination with etoposide (JET regimen) for childhood brain tumors. Am J Pediatr Hematol Oncol. 1990;12:297-300.
17. Cox DR, Oakes D. Analysis of survival data. London: Chapman and Hall. 1984.
18. Finlay JL, August C, Packer R, et al. High-dose multi-agent chemotherapy followed by bone marrow rescue for malignant astrocytomas of childhood and adolescence. J Neurooncol. 1990;9:239-248.
19. Heideman RL, Douglass EC, Krance RA, et al. High-dose chemotherapy and autologous bone marrow rescue followed by interstitial and external-beam radiotherapy in newly diagnosed pediatric malignant gliomas. J Clin Oncol. 1993;11:1458-1465.
20. Kedar A, Maria BL, Graham-Pole J, et al. High-dose chemotherapy with marrow reinfusion and hyperfractionated irradiation for children with high-risk brain tumors. Med Pediatr Oncol. 1994;23:428-436.
21. Bottom KS, Ashley DM, Friedman HS, et al. Evaluation of pre-radiotherapy cyclophosphamide in patients with newly diagnosed glioblastoma multiforme. Writing Committee for The Brain Tumor Center at Duke. J Neurooncol. 2000;46:151-156.
22. Grovas AC, Boyett JM, Lindsley K, et al. Regimen-related toxicity of myeloablative chemotherapy with BCNU, thiotepa, and etoposide followed by autologous stem cell rescue for children with newly diagnosed glioblastoma multiforme: report from the Children's Cancer Group. Med Pediatr Oncol. 1999;33:83-87.
23. Vinolas N, Gil M, Verger E, et al. Pre-irradiation semi-intensive chemotherapy with carboplatin and cyclophosphamide in malignant glioma: a phase II study. Anticancer Drugs. 2002;13:163-167.
24. Jeremic B, Shibamoto Y, Grujicic D, et al. Pre-irradiation carboplatin and etoposide and accelerated hyperfractionated radiation therapy in patients with high-grade astrocytomas: a phase II study. Radiother Oncol. 1999;51:27-33.
25. Finlay JL, Geyer JR, Turski PA, et al. Pre-irradiation chemotherapy in children with high-grade astrocytoma: tumor response to two cycles of the "8-drugs-in-1-day" regimen. A Children's Cancer Group study, CCG-945. J Neurooncol. 1994;21:255-265.
26. Hori M, Okubo T, Uozumi K, et al. T1-weighted fluid-attenuated inversion recovery at low field strength: a viable alternative for T1-weighted intracranial imaging. AJNR Am J Neuroradiol. 2003;24:648-651.
27. Kallen K, Burtscher IM, Hollas S, et al. 201Thallium SPECT and 1H-MRS compared with MRI in chemotherapy monitoring of high-grade malignant astrocytomas. J Neurooncol. 2000;46:173-185.
28. Braun V, Dempf S, Tomczak R, et al. Functional cranial neuronavigation. Direct integration of fMRI and PET data. J Neuroradiol. 2000;27:157-163.
29. Pollack IF, Hamilton RL, Burnham J, et al. Impact of proliferation index on outcome in childhood malignant gliomas: results in a multi-institutional cohort. Neurosurgery. 2002;50:1238-1244.
30. Ho DM, Wong TT, Hsu CY, et al. MIB-1 labeling index in nonpilocytic astrocytoma of childhood: a study of 101 cases. Cancer. 1998;82:2459-2466.
31. Pollack IF, Boyett JM, Yates AJ, et al. The influence of central review on outcome associations in childhood malignant gliomas: results from the CCG-945 experience. Neuro-oncol. 2003;5:197-207.
32. 6-Methylguanine- DNA methyltransferase in pediatric primary brain tumors: relation to patient and tumor characteristics. Clin Cancer Res. 2001;7:613-619.
33. Esteller M, Garcia-Foncillas J, Andion E, et al. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med. 2000;343:1350-1354.
34. 6-methylguanine-DNA methyltransferase-deficient phenotype in human gliomas: frequency and time to tumor progression after alkylating agent-based chemotherapy. Clin Cancer Res. 1999;5:807-814.
35. 6-Methylguanine-DNA methyltransferase protein levels in pediatric brain tumors. Clin Cancer Res. 1997;3:2459-2463.